Athersys Presents Data From Its Acute Respiratory Distress Syndrome Clinical Trial at American Thoracic Society International Conference
May 20, 2019 12:15 ET
|
Athersys, Inc.
CLEVELAND, May 20, 2019 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq: ATHX) announced additional favorable data from its exploratory Phase 1/2 acute respiratory distress syndrome (ARDS) clinical...
Athersys Announces Fast Track Designation From FDA for MultiStem® Program for Acute Respiratory Distress Syndrome
May 14, 2019 06:00 ET
|
Athersys, Inc.
CLEVELAND, May 14, 2019 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq: ATHX) announced today that its clinical program evaluating MultiStem® cell therapy for the treatment of Acute Respiratory Distress...
Athersys Reports First Quarter 2019 Results
May 08, 2019 16:05 ET
|
Athersys, Inc.
CLEVELAND, May 08, 2019 (GLOBE NEWSWIRE) -- Athersys, Inc. (NASDAQ: ATHX) announced today its financial results for the three months ended March 31, 2019. Highlights of the first quarter of 2019...
HEALIOS K.K. Announces Enrollment of First Patient in Japan in the ONE-BRIDGE Study of MultiStem® Treatment for Acute Respiratory Distress Syndrome
April 23, 2019 06:00 ET
|
Athersys, Inc.
CLEVELAND, Ohio, April 23, 2019 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq: ATHX) announced today that its partner, HEALIOS K.K. (“Healios”), has enrolled the first patient in its ONE-BRIDGE study...
Athersys to Host Investor Day in New York City
April 15, 2019 10:00 ET
|
Athersys, Inc.
CLEVELAND, Ohio, April 15, 2019 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq: ATHX) announced today that the company will host an investor day on Tuesday, May 14, 2019. The event will focus on the...
Athersys to Host First Quarter Financial Results Call
April 10, 2019 14:00 ET
|
Athersys, Inc.
CLEVELAND, April 10, 2019 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq: ATHX) will release its first quarter 2019 financial results at approximately 4:00 PM Eastern Time on Wednesday, May 8, 2019, and...
Athersys to Participate in Two Upcoming Healthcare Conferences
April 01, 2019 13:00 ET
|
Athersys, Inc.
CLEVELAND, April 01, 2019 (GLOBE NEWSWIRE) -- Athersys, Inc. (NASDAQ: ATHX) announced today the Company’s participation in two upcoming biotechnology and healthcare conferences. On April 4th,...
Athersys Announces Financial Results for Fourth Quarter and Full Year 2018
March 14, 2019 17:04 ET
|
Athersys, Inc.
Substantial progress over the year, advancing programs andexpanding collaboration with HEALIOS K.K. Management to host conference call at 4:30 PM EST today CLEVELAND, March 14, 2019 (GLOBE...
Athersys to Host Year-End 2018 Financial Results Call
February 14, 2019 08:00 ET
|
Athersys, Inc.
CLEVELAND, Feb. 14, 2019 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq: ATHX) will release its year-end 2018 financial results at approximately 4:00 PM Eastern Time on Thursday, March 14, 2019, and...
Athersys Announces Positive Results From Its Exploratory Clinical Study of MultiStem® Cell Therapy for Treatment of Acute Respiratory Distress Syndrome (ARDS)
January 23, 2019 06:00 ET
|
Athersys, Inc.
CLEVELAND, Jan. 23, 2019 (GLOBE NEWSWIRE) -- Athersys, Inc. (NASDAQ: ATHX) announced today summary results from its exploratory clinical study of the intravenous administration of MultiStem® cell...